Literature DB >> 30832984

Does the human placenta delivered at term have a microbiota? Results of cultivation, quantitative real-time PCR, 16S rRNA gene sequencing, and metagenomics.

Kevin R Theis1, Roberto Romero2, Andrew D Winters3, Jonathan M Greenberg3, Nardhy Gomez-Lopez4, Ali Alhousseini5, Janine Bieda6, Eli Maymon7, Percy Pacora6, Jennifer M Fettweis8, Gregory A Buck9, Kimberly K Jefferson10, Jerome F Strauss11, Offer Erez12, Sonia S Hassan13.   

Abstract

BACKGROUND: The human placenta has been traditionally viewed as sterile, and microbial invasion of this organ has been associated with adverse pregnancy outcomes. Yet, recent studies that utilized sequencing techniques reported that the human placenta at term contains a unique microbiota. These conclusions are largely based on the results derived from the sequencing of placental samples. However, such an approach carries the risk of capturing background-contaminating DNA (from DNA extraction kits, polymerase chain reaction reagents, and laboratory environments) when low microbial biomass samples are studied.
OBJECTIVE: To determine whether the human placenta delivered at term in patients without labor who undergo cesarean delivery harbors a resident microbiota ("the assemblage of microorganisms present in a defined niche or environment"). STUDY
DESIGN: This cross-sectional study included placentas from 29 women who had a cesarean delivery without labor at term. The study also included technical controls to account for potential background-contaminating DNA, inclusive in DNA extraction kits, polymerase chain reaction reagents, and laboratory environments. Bacterial profiles of placental tissues and background technical controls were characterized and compared with the use of bacterial culture, quantitative real-time polymerase chain reaction, 16S ribosomal RNA gene sequencing, and metagenomic surveys.
RESULTS: (1) Twenty-eight of 29 placental tissues had a negative culture for microorganisms. The microorganisms retrieved by culture from the remaining sample were likely contaminants because corresponding 16S ribosomal RNA genes were not detected in the same sample. (2) Quantitative real-time polymerase chain reaction did not indicate greater abundances of bacterial 16S ribosomal RNA genes in placental tissues than in technical controls. Therefore, there was no evidence of the presence of microorganisms above background contamination from reagents in the placentas. (3) 16S ribosomal RNA gene sequencing did not reveal consistent differences in the composition or structure of bacterial profiles between placental samples and background technical controls. (4) Most of the bacterial sequences obtained from metagenomic surveys of placental tissues were from cyanobacteria, aquatic bacteria, or plant pathogens, which are microbes unlikely to populate the human placenta. Coprobacillus, which constituted 30.5% of the bacterial sequences obtained through metagenomic sequencing of placental samples, was not identified in any of the 16S ribosomal RNA gene surveys of these samples. These observations cast doubt as to whether this organism is really present in the placenta of patients at term not in labor.
CONCLUSION: With the use of multiple modes of microbiologic inquiry, a resident microbiota could not be identified in human placentas delivered at term from women without labor. A consistently significant difference in the abundance and/or presence of a microbiota between placental tissue and background technical controls could not be found. All cultures of placental tissue, except 1, did not yield bacteria. Incorporating technical controls for potential sources of background-contaminating DNA for studies of low microbial biomass samples, such as the placenta, is necessary to derive reliable conclusions. Published by Elsevier Inc.

Entities:  

Keywords:  bacteria; bacterial culture; contamination; low microbial biomass sample; microbiome; microorganism; pregnancy; tissue

Mesh:

Substances:

Year:  2019        PMID: 30832984      PMCID: PMC6733039          DOI: 10.1016/j.ajog.2018.10.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   10.693


  276 in total

1.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

Review 2.  Chorioamnionitis and intraamniotic infection.

Authors:  E R Newton
Journal:  Clin Obstet Gynecol       Date:  1993-12       Impact factor: 2.190

Review 3.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

4.  The preterm placental microbiome varies in association with excess maternal gestational weight gain.

Authors:  Kathleen M Antony; Jun Ma; Kristen B Mitchell; Diana A Racusin; James Versalovic; Kjersti Aagaard
Journal:  Am J Obstet Gynecol       Date:  2014-12-31       Impact factor: 8.661

Review 5.  The vaginal microbiome: new information about genital tract flora using molecular based techniques.

Authors:  R F Lamont; J D Sobel; R A Akins; S S Hassan; T Chaiworapongsa; J P Kusanovic; R Romero
Journal:  BJOG       Date:  2011-01-20       Impact factor: 6.531

6.  Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection?

Authors:  Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Juan P Kusanovic; Nikolina Docheva; Alicia Martinez-Varea; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

7.  Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.

Authors:  Robert P Dickson; Benjamin H Singer; Michael W Newstead; Nicole R Falkowski; John R Erb-Downward; Theodore J Standiford; Gary B Huffnagle
Journal:  Nat Microbiol       Date:  2016-07-18       Impact factor: 17.745

8.  Blastococcus saxobsidens sp. nov., and emended descriptions of the genus Blastococcus Ahrens and Moll 1970 and Blastococcus aggregatus Ahrens and Moll 1970.

Authors:  Clara Urzì; Paola Salamone; Peter Schumann; Manfred Rohde; Erko Stackebrandt
Journal:  Int J Syst Evol Microbiol       Date:  2004-01       Impact factor: 2.747

9.  Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies.

Authors:  Anna Klindworth; Elmar Pruesse; Timmy Schweer; Jörg Peplies; Christian Quast; Matthias Horn; Frank Oliver Glöckner
Journal:  Nucleic Acids Res       Date:  2012-08-28       Impact factor: 16.971

10.  The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies.

Authors:  J Paul Brooks; David J Edwards; Michael D Harwich; Maria C Rivera; Jennifer M Fettweis; Myrna G Serrano; Robert A Reris; Nihar U Sheth; Bernice Huang; Philippe Girerd; Jerome F Strauss; Kimberly K Jefferson; Gregory A Buck
Journal:  BMC Microbiol       Date:  2015-03-21       Impact factor: 3.605

View more
  71 in total

1.  The development and ecology of the Japanese macaque gut microbiome from weaning to early adolescence in association with diet.

Authors:  Amanda L Prince; Ryan M Pace; Tyler Dean; Diana Takahashi; Paul Kievit; Jacob E Friedman; Kjersti M Aagaard
Journal:  Am J Primatol       Date:  2019-05-07       Impact factor: 2.371

Review 2.  Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children.

Authors:  Martha Scott Tomlinson; Kun Lu; Jill R Stewart; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Clin Microbiol Rev       Date:  2019-05-01       Impact factor: 26.132

Review 3.  Influence of maternal microbiota during pregnancy on infant immunity.

Authors:  D D Nyangahu; H B Jaspan
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

Review 4.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

5.  Fetal exposure to the maternal microbiota in humans and mice.

Authors:  Noelle Younge; Jessica R McCann; Julie Ballard; Catherine Plunkett; Suhail Akhtar; Félix Araújo-Pérez; Amy Murtha; Debra Brandon; Patrick C Seed
Journal:  JCI Insight       Date:  2019-10-03

6.  The first glimpse of the endometrial microbiota in early pregnancy.

Authors:  Inmaculada Moreno; Iolanda Garcia-Grau; Davide Bau; David Perez-Villaroya; Marta Gonzalez-Monfort; Felipe Vilella; Roberto Romero; Carlos Simón
Journal:  Am J Obstet Gynecol       Date:  2020-02-10       Impact factor: 8.661

7.  RNA Sequencing Reveals Distinct Immune Responses in the Chorioamniotic Membranes of Women with Preterm Labor and Microbial or Sterile Intra-amniotic Inflammation.

Authors:  Kenichiro Motomura; Roberto Romero; Jose Galaz; Adi L Tarca; Bogdan Done; Yi Xu; Yaozhu Leng; Valeria Garcia-Flores; Marcia Arenas-Hernandez; Kevin R Theis; Meyer Gershater; Eunjung Jung; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 8.  The Development of the Human Microbiome: Why Moms Matter.

Authors:  Derrick M Chu; Gregory C Valentine; Maxim D Seferovic; Kjersti M Aagaard
Journal:  Gastroenterol Clin North Am       Date:  2019-07-02       Impact factor: 3.806

9.  No bacteria found in healthy placentas.

Authors:  Nicola Segata
Journal:  Nature       Date:  2019-08       Impact factor: 49.962

Review 10.  Neonatal gut microbiome and immunity.

Authors:  Katherine Z Sanidad; Melody Y Zeng
Journal:  Curr Opin Microbiol       Date:  2020-07-04       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.